Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | GSK | ARGX | ||
| Company | Regeneron Pharmaceuticals | Gsk Plc ADR | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 714.99 | 50.65 | 812.03 | ||
| High | 727.39 | 50.92 | 827.80 | ||
| Low | 701.99 | 49.71 | 795.98 | ||
| Latest | 712.77 | 49.81 | 813.28 | ||
| Change | -2.12 | -0.60 | +31.11 | ||
| % Change | -0.30% | -1.19% | +3.98% | ||
| Volume | 1,227,100 | 3,575,500 | 497,900 | ||
| 20-Day Average Volume | 771,450 | 4,152,115 | 317,750 | ||
| Previous Close | 714.89 | 50.41 | 782.17 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 730.36 | 53.91 | 802.20 | ||
| 20-Day Raw Stochastic | 44.66% | 1.01% | 59.97% | ||
| 20-Day Relative Strength | 43.82 | 34.50 | 56.09 | ||
| Weighted Alpha | +18.62 | +25.12 | +35.52 | ||
| Today's Opinion | 24% Sell | 8% Buy | 40% Buy | ||
| Previous Opinion | 24% Sell | 8% Buy | 8% Sell | ||
| Last Month's Opinion | 16% Buy | 88% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.50% since 05/04/26 | -2.14% since 05/04/26 | +0.27% since 05/04/26 | ||
| Low | 699.22 on 05/05/26 | 49.71 on 05/11/26 | 777.14 on 05/07/26 | ||
| High | 727.39 on 05/11/26 | 51.22 on 05/06/26 | 840.67 on 05/07/26 | ||
| 1-Month | |||||
| %Chg | -4.82% since 04/10/26 | -14.43% since 04/10/26 | +1.70% since 04/10/26 | ||
| Low | 668.84 on 04/29/26 | 49.71 on 05/11/26 | 754.84 on 04/29/26 | ||
| High | 767.21 on 04/23/26 | 59.57 on 04/14/26 | 852.28 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | -8.50% since 02/11/26 | -14.84% since 02/11/26 | -2.55% since 02/11/26 | ||
| Low | 668.84 on 04/29/26 | 49.71 on 05/11/26 | 661.85 on 03/20/26 | ||
| High | 815.00 on 02/17/26 | 61.69 on 02/18/26 | 852.83 on 02/17/26 | ||
| 6-Month | |||||
| %Chg | +5.67% since 11/11/25 | +2.89% since 11/11/25 | -8.58% since 11/11/25 | ||
| Low | 668.84 on 04/29/26 | 45.81 on 11/20/25 | 661.85 on 03/20/26 | ||
| High | 821.11 on 01/09/26 | 61.69 on 02/18/26 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 75,578,176 | 102,291,872 | 48,641,580 | ||
| Shares Outstanding, K | 105,720 | 2,029,198 | 62,188 | ||
| Annual Sales | 14,342,900,000 | 43,077,970,000 | 4,248,050,000 | ||
| Annual Net Income | 4,504,900,000 | 7,537,690,000 | 1,292,040,000 | ||
| Last Quarter Sales | 3,605,400,000 | 10,280,080,000 | 1,322,160,000 | ||
| Last Quarter Net Income | 727,200,000 | 2,340,610,000 | 532,950,000 | ||
| 60-Month Beta | 0.30 | 0.38 | 0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 9.47 on 04/29/26 | 1.24 on 04/29/26 | 8.02 on 02/26/26 | ||
| Earnings Date | 08/07/26 | 07/29/26 | 07/30/26 | ||
| Most Recent Dividend | 0.940 on 02/20/26 | 0.470 on 02/20/26 | N/A | ||
| Next Ex-Dividends Date | 05/20/26 | 05/15/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 19.09 | 10.91 | 35.05 | ||